Antrin brand of motexafin lutetium
Semantic Scholar uses AI to extract papers important to this topic.
Sequelae of atherosclerotic vascular disease (for example, acute myocardial infarction or stroke) are leading causes of death… Expand The aim of this study was to evaluate the effect of superovulation treatment using combination of CIDR, FSH and hCG in beef… Expand Background—Motexafin lutetium (MLu; Antrin) is a photosensitizer that is taken up by atherosclerotic plaque and concentrated… Expand Photodynamic therapy (PDT) has been approved as a tissue‐specific light‐activated cytotoxic therapy for many diseases. The… Expand OBJECTIVE
Motexafin lutetium (Lu-Tex, Antrin Injection) is a photosensitizer that selectively accumulates in atheromatous plaque… Expand Pharmacyclics is developing the photosensitizer, motexafin lutetium as Antrin for the potential treatment of restenosis and… Expand ANTRINTM photosensitizer, a lutetium texaphyrin-containing drug, is currently being evaluated in the clinic as a phototherapeutic… Expand Mammalian prosomatostatin (PSS) is cleaved at a dibasic Arg-Lys site to produce somatostatin-14 (SS-14) and at monobasic Arg and… Expand Several peptides are generated from prosomatostatin (proSS) in addition to somatostatin-14 (SS-14) and somatostatin-28 (SS-28… Expand The three widely distributed peptides derived from prosomatostatin are the original neurohormone somatostatin-14, somatostatin-28… Expand